Biolife Solutions
(BLFS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 69,870 | 75,151 | 76,299 | 89,065 | 90,456 |
| Receivables | 23,217 | 20,232 | 21,093 | 10,669 | 8,006 |
| Inventories | 28,345 | 29,696 | 25,866 | 11,666 | 11,602 |
| TOTAL | $126,088 | $130,505 | $127,414 | $116,543 | $114,712 |
| Non-Current Assets | |||||
| PPE Net | 17,657 | 17,462 | 16,450 | 11,231 | 10,120 |
| Investments And Advances | 4,372 | 4,372 | 5,872 | 5,872 | 5,872 |
| Intangibles | 376,890 | 378,947 | 344,378 | 88,565 | 89,498 |
| Other Non-Current Assets | 29,279 | 28,105 | 26,855 | 17,813 | 14,627 |
| TOTAL | $428,198 | $428,886 | $393,555 | $123,481 | $120,117 |
| Total Assets | $554,286 | $559,391 | $520,969 | $240,024 | $234,829 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 862 | 3,932 | 6,296 | N/A | 614 |
| Accounts payable and accrued liabilities | 14,945 | 14,296 | 9,847 | 4,276 | 3,672 |
| Accrued Expenses | 6,870 | 12,057 | 9,911 | 8,146 | 4,543 |
| Other current liabilities | 17,116 | 2,714 | 2,854 | 2,390 | 5,629 |
| TOTAL | $42,700 | $35,793 | $31,275 | $16,381 | $15,573 |
| Non-Current Liabilities | |||||
| Long Term Debt | 6,353 | 6,122 | 5,019 | N/A | 655 |
| Other Non-Current Liabilities | 21,408 | 20,619 | 21,054 | 14,550 | 13,343 |
| TOTAL | $33,539 | $34,339 | $37,413 | $14,866 | $14,010 |
| Total Liabilities | $76,239 | $70,132 | $68,688 | $31,247 | $29,583 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 42,095 | 41,647 | 40,700 | 40,390 | 33,401 |
| Common Shares | 42 | 41 | 41 | 34 | 33 |
| Retained earnings | -107,110 | -90,548 | -90,627 | -98,503 | -97,385 |
| Other shareholders' equity | -282 | -163 | 3 | 0 | 0 |
| TOTAL | $478,047 | $489,259 | $452,281 | $208,777 | $205,246 |
| Total Liabilities And Equity | $554,286 | $559,391 | $520,969 | $240,024 | $234,829 |